Defunct Company
Total Trials
12
As Lead Sponsor
4
As Collaborator
8
Total Enrollment
1,118
NCT00809523
A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)
Phase: Phase 2/3
Role: Collaborator
Start: Dec 31, 2008
Completion: Apr 30, 2010
NCT01308424
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
Phase: Phase 1/2
Start: Jan 31, 2011
Completion: Nov 30, 2012
NCT01556971
Efficacy Study of Botox for Depression
Phase: Phase 4
Role: Lead Sponsor
Start: Feb 28, 2011
Completion: Jun 30, 2012
NCT01340066
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
Start: Apr 30, 2011
Completion: May 31, 2012
NCT01902303
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
Phase: Phase 2
Start: Jul 31, 2013
Completion: Feb 28, 2015
NCT03027830
iFR Pressure Wires in Assessment of the Provisional Side-branch Intervention Strategy for Bifurcation Lesions
Phase: N/A
Start: Mar 31, 2014
Completion: Jan 31, 2017
NCT02084290
Evaluating a Shared Decision Making Program for Crohn's Disease
Completion: Dec 31, 2018
NCT02278328
MEG Study of Acute STX209 Effects in ASD
Phase: Early Phase 1
Start: Feb 29, 2016
Completion: Sep 27, 2019
NCT02929316
Vedolizumab Induction May Prevent Celiac Enteritis
Start: Jun 25, 2018
Completion: Oct 5, 2018
NCT04522830
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
Start: Jul 30, 2020
Completion: Feb 28, 2021
NCT04749680
Comparison of Efficacy and Tolerability of APD Treatment With Different PD Cyclers
Start: May 31, 2021
Completion: Oct 12, 2021
NCT04271332
Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion
Start: Sep 1, 2022
Completion: Mar 23, 2025